Growth Metrics

Veon (VEON) Cash & Equivalents (2016 - 2025)

Veon has reported Cash & Equivalents over the past 16 years, most recently at $1.7 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 2.55% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 2.55%, while the annual FY2025 figure was $1.7 billion, 2.55% up from the prior year.
  • Cash & Equivalents was $1.7 billion for Q4 2025 at Veon, up from $1.3 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.5 billion in Q2 2023 and bottomed at $4.0 million in Q4 2023.
  • The 5-year median for Cash & Equivalents is $1.4 billion (2021), against an average of $1.2 billion.
  • Year-over-year, Cash & Equivalents tumbled 88.89% in 2022 and then surged 42125.0% in 2024.
  • Over 5 years, Cash & Equivalents stood at $54.0 million in 2021, then tumbled by 88.89% to $6.0 million in 2022, then crashed by 33.33% to $4.0 million in 2023, then surged by 42125.0% to $1.7 billion in 2024, then increased by 2.55% to $1.7 billion in 2025.
  • The last three reported values for Cash & Equivalents were $1.7 billion (Q4 2025), $1.3 billion (Q2 2025), and $1.7 billion (Q4 2024) per Business Quant data.